Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Ochrobactrum anthropi Adenylate kinase (adk) CSB-YP409692ODH
CSB-EP409692ODH
CSB-BP409692ODH
CSB-MP409692ODH
CSB-EP409692ODH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ochrobactrum anthropi Glutamate racemase (murI) CSB-YP409693ODH
CSB-EP409693ODH
CSB-BP409693ODH
CSB-MP409693ODH
CSB-EP409693ODH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ochrobactrum anthropi Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase (lpxA) CSB-YP409694ODH
CSB-EP409694ODH
CSB-BP409694ODH
CSB-MP409694ODH
CSB-EP409694ODH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ochrobactrum anthropi 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA) CSB-YP409695ODH
CSB-EP409695ODH
CSB-BP409695ODH
CSB-MP409695ODH
CSB-EP409695ODH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ochrobactrum anthropi Flavoprotein wrbA (wrbA) CSB-YP409696ODH
CSB-EP409696ODH
CSB-BP409696ODH
CSB-MP409696ODH
CSB-EP409696ODH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ochrobactrum anthropi ATP-dependent Clp protease ATP-binding subunit ClpX (clpX) CSB-YP409697ODH
CSB-EP409697ODH
CSB-BP409697ODH
CSB-MP409697ODH
CSB-EP409697ODH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ochrobactrum anthropi Sec-independent protein translocase protein TatA (tatA), partial CSB-YP409698ODH
CSB-EP409698ODH
CSB-BP409698ODH
CSB-MP409698ODH
CSB-EP409698ODH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ochrobactrum anthropi tRNA 2-thiocytidine biosynthesis protein TtcA (ttcA) CSB-YP409699ODH
CSB-EP409699ODH
CSB-BP409699ODH
CSB-MP409699ODH
CSB-EP409699ODH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ochrobactrum anthropi NADH-quinone oxidoreductase subunit H (nuoH), partial CSB-YP409700ODH
CSB-EP409700ODH
CSB-BP409700ODH
CSB-MP409700ODH
CSB-EP409700ODH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ochrobactrum anthropi Urease accessory protein UreD 2 (ureD2) CSB-YP409701ODH
CSB-EP409701ODH
CSB-BP409701ODH
CSB-MP409701ODH
CSB-EP409701ODH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ochrobactrum anthropi Integration host factor subunit alpha (ihfA) CSB-YP409702ODH
CSB-EP409702ODH
CSB-BP409702ODH
CSB-MP409702ODH
CSB-EP409702ODH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ochrobactrum anthropi Aspartate--tRNA ligase (aspS), partial CSB-YP409703ODH
CSB-EP409703ODH
CSB-BP409703ODH
CSB-MP409703ODH
CSB-EP409703ODH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ochrobactrum anthropi DNA-directed RNA polymerase subunit omega (rpoZ) CSB-YP409704ODH
CSB-EP409704ODH
CSB-BP409704ODH
CSB-MP409704ODH
CSB-EP409704ODH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ochrobactrum anthropi Fructose-1,6-bisphosphatase class 1 (fbp) CSB-YP409705ODH
CSB-EP409705ODH
CSB-BP409705ODH
CSB-MP409705ODH
CSB-EP409705ODH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ochrobactrum anthropi DNA mismatch repair protein mutL (mutL), partial CSB-YP409706ODH
CSB-EP409706ODH
CSB-BP409706ODH
CSB-MP409706ODH
CSB-EP409706ODH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ochrobactrum anthropi C4-dicarboxylate transport protein (dctA), partial CSB-YP409707ODH
CSB-EP409707ODH
CSB-BP409707ODH
CSB-MP409707ODH
CSB-EP409707ODH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ochrobactrum anthropi Lectin-like protein BA14k (Oant_3884), partial CSB-YP409708ODH1
CSB-EP409708ODH1
CSB-BP409708ODH1
CSB-MP409708ODH1
CSB-EP409708ODH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ochrobactrum anthropi Flagellar hook-basal body complex protein FliE (fliE) CSB-YP409709ODH
CSB-EP409709ODH
CSB-BP409709ODH
CSB-MP409709ODH
CSB-EP409709ODH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Transcription factor tau subunit sfc7 (sfc7) CSB-YP409710SXV
CSB-EP409710SXV
CSB-BP409710SXV
CSB-MP409710SXV
CSB-EP409710SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Trichophyton rubrum Metallocarboxypeptidase A (MCPA) CSB-YP409711TQA
CSB-EP409711TQA
CSB-BP409711TQA
CSB-MP409711TQA
CSB-EP409711TQA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>